Table 1 Nongestational choriocarcinoma of the ovary: a summary of cases
From: Pure nongestational choriocarcinoma of the ovary: a case report
Authors (Reference) | Age | β-human chorionic gonadotropin (mIU/ml) | Surgery | Chemotherapy | Outcome |
|---|---|---|---|---|---|
Gerson[10] | 33 | 564,000 | Right salpingo-oophorectomy | Etoposide, methotrexate, actinomycin-D, cyclophosphamide, vincristine | No evidence of disease |
Yamamoto[11] | 19 | 206,949 | Left oophorectomy | Etoposide, methotrexate, actinomycin-D | No evidence of disease |
Balat[9] | 24 | 8,968 | TAH, BSO, PLND, partial omentectomy, and sternum mass excision | Bleomycin, etoposide, cisplatin | Died during chemotherapy |
Roghaei[12] | 47 | 970 | TAH, BSO, PLND, and partial omentectomy | Etoposide, methotrexate, actinomycin-D, cyclophosphamide, vincristine | No evidence of disease |
Byeun[13] | 28 | 13,378 | Right salpingo-oophorectomy | Etoposide, methotrexate, actinomycin-D | No evidence of disease |
Corakci[14] | 22 | 15,050 | TAH, BSO, PLND, and PaLND | Bleomycin, etoposide, cisplatin | No evidence of disease |
Lyn[15] | 48 | 7,663 | TAH, BSO, PLND, PaLND, omentectomy, appendectomy, and peritoneal biopsy | Bleomycin, etoposide, cisplatin | No evidence of disease |